Related Experiment Video
Updated: Sep 6, 2025

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
Published on: January 5, 2024
Filamentous Pseudomonas Phage Pf4 in the Context of Therapy-Inducibility, Infectivity, Lysogenic Conversion, and
Damir Gavric1, Petar Knezevic1
1PK Lab, Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovica 2, 21000 Novi Sad, Vojvodina, Serbia.
Abstract:
More than 20% of all Pseudomonas aeruginosa are infected with Pf4-related filamentous phage and although their role in virulence of P. aeruginosa strain PAO1 is well documented, its properties related to therapy are not elucidated in detail. The aim of this study was to determine how phage and antibiotic therapy induce Pf4, whether the released virions can infect other strains and how the phage influences the phenotype of new hosts. The subinhibitory concentrations of ciprofloxacin and mitomycin C increased Pf4 production for more than 50% during the first and sixth hour of exposure, respectively, while mutants appearing after infection with obligatory lytic phage at low MOI produced Pf4 more than four times after 12-24 h of treatment. This indicates that production of Pf4 is enhanced during therapy with these agents. The released virions can infect new P. aeruginosa strains, as confirmed for models UCBPP-PA14 (PA14) and LESB58, existing both episomally and in a form of a prophage, as confirmed by PCR, RFLP, and sequencing. The differences in properties of Pf4-infected, and uninfected PA14 and LESB58 strains were obvious, as infection with Pf4 significantly decreased cell autoaggregation, pyoverdine, and pyocyanin production, while significantly increased swimming motility and biofilm production in both strains. In addition, in strain PA14, Pf4 increased cell surface hydrophobicity and small colony variants' appearance, but also decreased twitching and swarming motility. This indicates that released Pf4 during therapy can infect new strains and cause lysogenic conversion. The infection with Pf4 increased LESB58 sensitivity to ciprofloxacin, gentamicin, ceftazidime, tetracycline, and streptomycin, and PA14 to ciprofloxacin and ceftazidime. Moreover, the Pf4-infected LESB58 was re-sensitized to ceftazidime and tetracycline, with changes from resistant to intermediate resistant and sensitive, respectively. The obtained results open a new field in phage therapy-treatment with selected filamentous phages in order to re-sensitize pathogenic bacteria to certain antibiotics. However, this approach should be considered with precautions, taking into account potential lysogenic conversion.
Insights
Antibiotic therapy can enhance Pf4 phage production in Pseudomonas aeruginosa, leading to phage spread and altered bacterial traits. This phage infection can re-sensitize bacteria to antibiotics, offering a novel therapeutic avenue.
Area of Science:
- Microbiology
- Bacteriology
- Virology
Background:
- Pseudomonas aeruginosa frequently harbors Pf4-related filamentous phages.
- The role of Pf4 phage in P. aeruginosa virulence is known, but its therapeutic implications are less understood.
- Understanding phage-antibiotic interactions is crucial for developing new treatment strategies.
Purpose of the Study:
- To investigate how phage and antibiotic therapy affect Pf4 production in P. aeruginosa.
- To determine if released Pf4 virions can infect other bacterial strains.
- To analyze the impact of Pf4 infection on the phenotype and antibiotic susceptibility of new hosts.
Main Methods:
- Exposure of P. aeruginosa to subinhibitory concentrations of ciprofloxacin and mitomycin C.
- Infection with lytic phage to induce Pf4 production.
- Confirmation of Pf4 infection in new strains (PA14, LESB58) using PCR, RFLP, and sequencing.
- Phenotypic analysis including autoaggregation, motility, biofilm formation, and hydrophobicity.
- Antibiotic susceptibility testing before and after Pf4 infection.
Main Results:
- Subinhibitory antibiotic concentrations and lytic phage infection significantly increased Pf4 production.
- Released Pf4 virions successfully infected and established lysogeny in new P. aeruginosa strains.
- Pf4 infection altered bacterial phenotypes, decreasing autoaggregation and pyoverdine/pyocyanin production, while increasing motility and biofilm formation.
- Pf4 infection modified antibiotic susceptibility, with some strains becoming re-sensitized to specific antibiotics.
Conclusions:
- Therapeutic interventions can enhance Pf4 phage production and spread in P. aeruginosa populations.
- Lysogenic conversion by Pf4 can significantly alter bacterial characteristics and antibiotic sensitivity.
- Targeted use of filamentous phages like Pf4 presents a potential strategy for combating antibiotic resistance by re-sensitizing bacteria to antibiotics.
- Further research is needed to explore this approach cautiously, considering potential unintended consequences of lysogenic conversion.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
DNA Bacteriophages
Viral Replication: Lytic Cycle
Gene Regulation in Microbial Communities: Quorum Sensing

